BMY
Price
$45.47
Change
+$0.11 (+0.24%)
Updated
Aug 8, 12:30 PM (EDT)
Capitalization
109.66B
83 days until earnings call
HAWPF
Price
$10.62
Change
+$1.22 (+12.98%)
Updated
Aug 5 closing price
Capitalization
1.62B
Interact to see
Advertisement

BMY vs HAWPF

Header iconBMY vs HAWPF Comparison
Open Charts BMY vs HAWPFBanner chart's image
Bristol-Myers Squibb
Price$45.47
Change+$0.11 (+0.24%)
Volume$7.97K
Capitalization109.66B
Haw Par
Price$10.62
Change+$1.22 (+12.98%)
Volume$100
Capitalization1.62B
BMY vs HAWPF Comparison Chart in %
Loading...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAWPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMY vs. HAWPF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a StrongBuy and HAWPF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BMY: $45.36 vs. HAWPF: $10.62)
Brand notoriety: BMY: Notable vs. HAWPF: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 96% vs. HAWPF: 30%
Market capitalization -- BMY: $109.66B vs. HAWPF: $1.62B
BMY [@Pharmaceuticals: Major] is valued at $109.66B. HAWPF’s [@Pharmaceuticals: Major] market capitalization is $1.62B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 2 FA rating(s) are green whileHAWPF’s FA Score has 1 green FA rating(s).

  • BMY’s FA Score: 2 green, 3 red.
  • HAWPF’s FA Score: 1 green, 4 red.
According to our system of comparison, HAWPF is a better buy in the long-term than BMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 5 TA indicator(s) are bullish while HAWPF’s TA Score has 3 bullish TA indicator(s).

  • BMY’s TA Score: 5 bullish, 5 bearish.
  • HAWPF’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, BMY is a better buy in the short-term than HAWPF.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а +4.73% price change this week, while HAWPF (@Pharmaceuticals: Major) price change was +12.98% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.76%. For the same industry, the average monthly price growth was +5.97%, and the average quarterly price growth was +13.59%.

Reported Earning Dates

BMY is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.76% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMY($110B) has a higher market cap than HAWPF($1.62B). HAWPF (13.91) and BMY (13.73) have similar P/E ratio . HAWPF YTD gains are higher at: 32.750 vs. BMY (-16.957). BMY has higher annual earnings (EBITDA): 19.4B vs. HAWPF (149M). BMY has more cash in the bank: 12.3B vs. HAWPF (3.09B). HAWPF has less debt than BMY: HAWPF (12.9M) vs BMY (41.5B). BMY has higher revenues than HAWPF: BMY (45B) vs HAWPF (171M).
BMYHAWPFBMY / HAWPF
Capitalization110B1.62B6,786%
EBITDA19.4B149M13,020%
Gain YTD-16.95732.750-52%
P/E Ratio13.7313.9199%
Revenue45B171M26,316%
Total Cash12.3B3.09B398%
Total Debt41.5B12.9M321,705%
FUNDAMENTALS RATINGS
BMY vs HAWPF: Fundamental Ratings
BMY
HAWPF
OUTLOOK RATING
1..100
6744
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
88
Overvalued
PROFIT vs RISK RATING
1..100
10043
SMR RATING
1..100
3373
PRICE GROWTH RATING
1..100
6244
P/E GROWTH RATING
1..100
5228
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMY's Valuation (3) in the Pharmaceuticals Major industry is significantly better than the same rating for HAWPF (88) in the null industry. This means that BMY’s stock grew significantly faster than HAWPF’s over the last 12 months.

HAWPF's Profit vs Risk Rating (43) in the null industry is somewhat better than the same rating for BMY (100) in the Pharmaceuticals Major industry. This means that HAWPF’s stock grew somewhat faster than BMY’s over the last 12 months.

BMY's SMR Rating (33) in the Pharmaceuticals Major industry is somewhat better than the same rating for HAWPF (73) in the null industry. This means that BMY’s stock grew somewhat faster than HAWPF’s over the last 12 months.

HAWPF's Price Growth Rating (44) in the null industry is in the same range as BMY (62) in the Pharmaceuticals Major industry. This means that HAWPF’s stock grew similarly to BMY’s over the last 12 months.

HAWPF's P/E Growth Rating (28) in the null industry is in the same range as BMY (52) in the Pharmaceuticals Major industry. This means that HAWPF’s stock grew similarly to BMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMYHAWPF
RSI
ODDS (%)
Bullish Trend 1 day ago
55%
Bearish Trend 1 day ago
35%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
50%
Bearish Trend 1 day ago
21%
Momentum
ODDS (%)
Bearish Trend 1 day ago
55%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
42%
Bullish Trend 1 day ago
33%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
51%
Bullish Trend 1 day ago
28%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 1 day ago
28%
Advances
ODDS (%)
Bullish Trend 4 days ago
53%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
54%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
58%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
HAWPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
INDA52.530.27
+0.53%
iShares MSCI India ETF
BSMU21.700.03
+0.13%
Invesco BulletShares 2030 Muncpl Bd ETF
PBQQ27.300.01
+0.04%
PGIM LADDERED NASDAQ-100 BUFFER 12 ETF
QQQJ33.430.01
+0.03%
Invesco NASDAQ Next Gen 100 ETF
ZIG36.23-0.58
-1.58%
The Acquirers ETF

HAWPF and

Correlation & Price change

A.I.dvisor tells us that HAWPF and CSWYF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HAWPF and CSWYF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HAWPF
1D Price
Change %
HAWPF100%
N/A
CSWYF - HAWPF
27%
Poorly correlated
N/A
RHHVF - HAWPF
21%
Poorly correlated
+0.37%
BMY - HAWPF
20%
Poorly correlated
+1.20%
GLAXF - HAWPF
8%
Poorly correlated
N/A
OPHLY - HAWPF
8%
Poorly correlated
-0.45%
More